The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Nephelometry and Turbidimetry

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Nephelometry and Turbidimetry

 

Psychiatry related information on Nephelometry and Turbidimetry

 

High impact information on Nephelometry and Turbidimetry

 

Chemical compound and disease context of Nephelometry and Turbidimetry

 

Biological context of Nephelometry and Turbidimetry

 

Anatomical context of Nephelometry and Turbidimetry

 

Associations of Nephelometry and Turbidimetry with chemical compounds

  • BACKGROUND: Citrated platelet-rich plasma (PRP) turbidimetry is used for assessing pharmacodynamic effects of glycoprotein (GP) IIb/IIIa antagonists in clinical trials [10].
  • METHODS AND RESULTS: Three GP IIb/IIIa antagonists, eptifibatide, MK-0852, and GR144053, were compared in PRP (turbidimetry) and whole blood (platelet counting with an Ultra-Flo 100 Platelet Counter), with ADP and collagen used as agonists [10].
  • Since we hypothesize that the morphological changes of the few platelets that adhere to collagen might not be revealed by turbidimetry, the aim of this study was to assess platelet shape change using transmission electron microscopy, in the absence of the amplificatory feedback pathways of ADP and thromboxane A(2) [24].
  • C-reactive protein (CRP) was measured by latex-enhanced nephelometry [25].
  • These increases were found for particulate matter with a diameter less than 2.5 microm (PM2.5) and less than 10 microm (PM10), nephelometry, NO2, and SO2 [26].
 

Gene context of Nephelometry and Turbidimetry

  • Clotting was induced by addition of tissue factor to recalcified plasma in the absence or presence of TM, and clot formation was monitored using turbidimetry [27].
  • CRP was measured by nephelometry and IL-6 bioassay [28].
  • MMP-2 and MMP-9 were also measured by a zymogram protease assay. alpha2 macroglobulin (AMG) was measured by nephelometry [29].
  • C3, C4, factor B, C-reactive protein (CRP), fibrinogen, ceruloplasmin (Cp) and alpha(1)-antitrypsin (AAT) were assayed by a rate nephelometry [30].
  • In this study, we developed an automated method for measuring SAA4 concentration in serum by kinetic nephelometry of anti-SAA4 antibody-coated latex agglutination [31].
 

Analytical, diagnostic and therapeutic context of Nephelometry and Turbidimetry

References

  1. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Storey, R.F., May, J.A., Wilcox, R.G., Heptinstall, S. Thromb. Haemost. (1999) [Pubmed]
  2. A mechanism of macroscopic (amorphous) aggregation of the tobacco mosaic virus coat protein. Rafikova, E.R., Kurganov, B.I., Arutyunyan, A.M., Kust, S.V., Drachev, V.A., Dobrov, E.N. Int. J. Biochem. Cell Biol. (2003) [Pubmed]
  3. Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Ricker, D.M., Hebert, L.A., Rohde, R., Sedmak, D.D., Lewis, E.J., Clough, J.D. Am. J. Kidney Dis. (1991) [Pubmed]
  4. Diminished IgG, but not complement C3 or C4 or factor B, precedes nosocomial bacterial sepsis in very low birth weight neonates. Lassiter, H.A., Tanner, J.E., Cost, K.M., Steger, S., Vogel, R.L. Pediatr. Infect. Dis. J. (1991) [Pubmed]
  5. Cytolysis of B-16 melanoma tumor cells mediated by the myeloperoxidase and lactoperoxidase systems. Odajima, T., Onishi, M., Hayama, E., Motoji, N., Momose, Y., Shigematsu, A. Biol. Chem. (1996) [Pubmed]
  6. Usefulness of C-reactive protein in the diagnosis of neonatal sepsis. Chan, D.K., Ho, L.Y. Singapore medical journal. (1997) [Pubmed]
  7. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. Kernen, P., Wymann, M.P., von Tscharner, V., Deranleau, D.A., Tai, P.C., Spry, C.J., Dahinden, C.A., Baggiolini, M. J. Clin. Invest. (1991) [Pubmed]
  8. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile. Van Erpecum, K.J., Portincasa, P., Eckhardt, E., Go, P.M., VanBerge-Henegouwen, G.P., Groen, A.K. Gastroenterology (1996) [Pubmed]
  9. Interaction of bovine gallbladder mucin and calcium-binding protein: effects on calcium phosphate precipitation. Afdhal, N.H., Ostrow, J.D., Koehler, R., Niu, N., Groen, A.K., Veis, A., Nunes, D.P., Offner, G.D. Gastroenterology (1995) [Pubmed]
  10. Differential effects of glycoprotein IIb/IIIa antagonists on platelet microaggregate and macroaggregate formation and effect of anticoagulant on antagonist potency. Implications for assay methodology and comparison of different antagonists. Storey, R.F., Wilcox, R.G., Heptinstall, S. Circulation (1998) [Pubmed]
  11. Rheumatoid factor in the serum of hepatitis C virus-infected patients: an increase in the titre during cold storage. Ueda, K., Nakagawa, T., Shimizu, A., Nakajima, H., Fukuda, A., Ohsawa, N. Ann. Clin. Biochem. (1996) [Pubmed]
  12. Aggregation of tobacco mosaic virus by sodium chondroitin sulfate. Sano, Y., Inoue, H. Microbiol. Immunol. (1980) [Pubmed]
  13. Comparative antibacterial effects of amoxycillin, amoxycillin/clavulanic acid and cefotaxime against Enterobacteriaceae as determined by turbidimetry, morphology and viable count. Wilson, J.M., Hunter, P.A. Chemotherapy. (1986) [Pubmed]
  14. Immune complexes in solid tumours precipitable by 3.5% polyethylene glycol: analysis of some nonspecific components. Guidi, L., Baroni, R., Bartoloni, C., Pellegrino, M., Tricerri, A., Marciano, M., Barone, C., Gambassi, G. Diagnostic and clinical immunology. (1988) [Pubmed]
  15. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy. Lopes de Faria, J.M., Silveira, L.A., Morgano, M., Pavin, E.J., Lopes de Faria, J.B. Invest. Ophthalmol. Vis. Sci. (2000) [Pubmed]
  16. Is microtubule assembly a biphasic process? A fluorimetric study using 4',6-diamidino-2-phenylindole as a probe. Heusele, C., Bonne, D., Carlier, M.F. Eur. J. Biochem. (1987) [Pubmed]
  17. The function of elevated plasma fibronectin in preeclampsia. Brubaker, D.B., Ross, M.G., Marinoff, D. Am. J. Obstet. Gynecol. (1992) [Pubmed]
  18. Relevance of carbohydrate-deficient transferrin as a predictor of alcoholism in intensive care patients following trauma. Spies, C.D., Emadi, A., Neumann, T., Hannemann, L., Rieger, A., Schaffartzik, W., Rahmanzadeh, R., Berger, G., Funk, T., Blum, S. The Journal of trauma. (1995) [Pubmed]
  19. Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers. van Antwerpen, V.L., Theron, A.J., Richards, G.A., Steenkamp, K.J., van der Merwe, C.A., van der Walt, R., Anderson, R. Free Radic. Biol. Med. (1995) [Pubmed]
  20. Elevated ascitic fluid fibronectin concentration. A non-specific finding. Runyon, B.A. J. Hepatol. (1986) [Pubmed]
  21. The binding of the radioprotective agent cysteamine with the phospholipidic membrane headgroup-interface region. Berleur, F., Roman, V., Jaskierowicz, D., Fatome, M., Leterrier, F., Ter-Minassian-Saraga, L., Madelmont, G. Biochem. Pharmacol. (1985) [Pubmed]
  22. Pyruvate kinase as a microtubule destabilizing factor in vitro. Vértessy, B.G., Bánkfalvi, D., Kovács, J., Löw, P., Lehotzky, A., Ovádi, J. Biochem. Biophys. Res. Commun. (1999) [Pubmed]
  23. Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk. Solerte, S.B., Fioravanti, M., Pezza, N., Locatelli, M., Schifino, N., Cerutti, N., Severgnini, S., Rondanelli, M., Ferrari, E. Int. J. Obes. Relat. Metab. Disord. (1997) [Pubmed]
  24. Collagen-induced platelet shape change is not affected by positive feedback pathway inhibitors and cAMP-elevating agents. Riondino, S., Lotti, L.V., Cutini, L., Pulcinelli, F.M. J. Biol. Chem. (2005) [Pubmed]
  25. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Ford, E.S., Ajani, U.A., Mokdad, A.H. Diabetes Care (2005) [Pubmed]
  26. Air pollution and child respiratory health: a case-crossover study in Australia and New Zealand. Barnett, A.G., Williams, G.M., Schwartz, J., Neller, A.H., Best, T.L., Petroeschevsky, A.L., Simpson, R.W. Am. J. Respir. Crit. Care Med. (2005) [Pubmed]
  27. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma. Elisen, M.G., von dem Borne, P.A., Bouma, B.N., Meijers, J.C. Blood (1998) [Pubmed]
  28. Lipopolysaccharide binding protein as a marker of inflammation in synovial fluid of patients with arthritis: correlation with interleukin 6 and C-reactive protein. Heumann, D., Bas, S., Gallay, P., Le Roy, D., Barras, C., Mensi, N., Glauser, M.P., Vischer, T. J. Rheumatol. (1995) [Pubmed]
  29. Matrix metalloproteinases and their inhibitors in acute viral hepatitis. Koulentaki, M., Valatas, V., Xidakis, K., Kouroumalis, A., Petinaki, E., Castanas, E., Kouroumalis, E. J. Viral Hepat. (2002) [Pubmed]
  30. The acute phase response in Sicilian patients with boutonneuse fever admitted to hospitals in Palermo, 1992-1997. Vitale, G., Mansueto, S., Gambino, G., Mocciaro, C., Spinelli, A., Rini, G.B., Affronti, M., Chifari, N., La Russa, C., Di Rosa, S., Colletti, P., Barbera, C., La Rosa, M., Di Bella, G., Ferlazzo, V., Milano, S., D'Agostino, P., Cillari, E. J. Infect. (2001) [Pubmed]
  31. Automated measurement of a constitutive isotype of serum amyloid A/SAA4 and comparison with other apolipoproteins. Yamada, T., Wada, A., Yamaguchi, T., Itoh, Y., Kawai, T. J. Clin. Lab. Anal. (1997) [Pubmed]
  32. Serum IgA-mediated neutralization of HIV type 1. Burnett, P.R., VanCott, T.C., Polonis, V.R., Redfield, R.R., Birx, D.L. J. Immunol. (1994) [Pubmed]
  33. Mechanisms of severe, immediate reactions to iodinated contrast material. Laroche, D., Aimone-Gastin, I., Dubois, F., Huet, H., Gérard, P., Vergnaud, M.C., Mouton-Faivre, C., Guéant, J.L., Laxenaire, M.C., Bricard, H. Radiology. (1998) [Pubmed]
  34. Four immunochemical methods for measuring C-reactive protein in plasma compared. Grützmeier, S., von Schenck, H. Clin. Chem. (1989) [Pubmed]
  35. Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Rallidis, L.S., Paschos, G., Liakos, G.K., Velissaridou, A.H., Anastasiadis, G., Zampelas, A. Atherosclerosis (2003) [Pubmed]
  36. Comparison of methods for measuring albumin in peritoneal dialysis and hemodialysis patients. Joseph, R., Tria, L., Mossey, R.T., Bellucci, A.G., Mailloux, L.U., Vernace, M.A., Miller, I., Wilkes, B.M. Am. J. Kidney Dis. (1996) [Pubmed]
 
WikiGenes - Universities